Orchid Pharma Limited (BOM:524372)

Orchid Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	50,823	24,469	39,363	52,994	15,643	11,641
Market Cap Growth	32.24%	-37.84%	-25.72%	238.77%	34.38%	-88.15%
Enterprise Value	53,617	25,800	38,574	53,964	18,909	14,449
Last Close Price	997.45	478.35	776.90	1045.20	384.40	284.30

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	172.49	119.09	39.50	57.50	33.77	-
PS Ratio	5.96	3.02	4.27	6.47	2.35	2.08
PB Ratio	3.95	1.90	3.11	4.53	2.27	1.80
P/TBV Ratio	4.19	2.02	3.15	4.59	2.27	1.80
P/FCF Ratio	-	-	-	86.62	-	14.91
P/OCF Ratio	50.22	24.18	204.86	42.06	85.30	12.59

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	6.29	3.18	4.18	6.59	2.84	2.58
EV/EBITDA Ratio	90.12	62.73	32.97	49.33	22.57	27.21
EV/EBIT Ratio	226.33	454.59	46.50	69.52	65.22	-
EV/FCF Ratio	-	-	-	88.21	-	18.51

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.28	0.28	0.14	0.12	0.48	0.41
Debt / EBITDA Ratio	7.11	8.82	1.49	1.23	3.96	5.05
Debt / FCF Ratio	-	-	-	2.21	-	3.43
Net Debt / Equity Ratio	0.22	0.22	0.12	0.11	0.44	0.41
Net Debt / EBITDA Ratio	5.48	6.79	1.31	1.20	3.64	4.97
Net Debt / FCF Ratio	-	-0.99	-1.17	2.15	-4.58	3.38
Asset Turnover	-	0.45	0.57	0.59	0.57	0.48
Inventory Turnover	-	1.81	1.92	2.04	2.00	2.01
Quick Ratio	-	1.25	0.93	0.79	0.65	0.73
Current Ratio	-	2.45	2.83	3.04	1.35	1.65
Return on Equity (ROE)	-	1.61%	8.18%	9.92%	7.95%	-9.29%
Return on Assets (ROA)	-	0.20%	3.20%	3.49%	1.55%	-1.80%
Return on Capital Employed (ROCE)	-	0.30%	5.90%	6.00%	3.40%	-3.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	0.58%	0.84%	2.53%	1.74%	2.96%	-0.17%
FCF Yield	-5.56%	-11.54%	-3.33%	1.15%	-4.26%	6.71%
Buyback Yield / Dilution	0.08%	-0.03%	-4.87%	-18.49%	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error